A more effective shingles vaccine is expected to become available in South Africa by the end of June 2026. However, its price and planned private-sector launch could place it beyond the reach of many patients. Shingrix is manufactured by pharmaceutical company GlaxoSmithKline, or GSK. The South African Health Products Regulatory Authority recently registered the vaccine. SAHPRA registration means Shingrix can…
Tag: Vaccine Access
-
New COVID-19 Variant No Threat to South Africa
While the COVID-19 pandemic has subsided from its peak, the virus continues to circulate and evolve globally. The recent designation of a new variant, NB.1.8.1, by the World Health Organisation (WHO) has sparked online discussion. South Africa’s leading scientists are urging calm while highlighting a more pressing local issue: vaccine accessibility. The National Institute for Communicable Diseases (NICD) has confirmed…
-
Future Pandemic Preparedness: South Africa’s Warning
South Africa’s future pandemic preparedness has dwindled. This is compared to its readiness in 2020. The reasons include healthcare cuts and a waning sense of vigilance. It has been five years since the COVID-19 lockdown. Top virologist Professor Shabir Madhi has a warning. He says the healthcare system has deteriorated. Progress Hindered Initial public health investments were made. However, progress…